Normoftal for Eye Health & Visual System Support — Bioregulators
Khavinson bioregulator peptide for comprehensive ocular health and visual system optimization.
Overview
Normoftal is a Khavinson synthetic bioregulator that targets the visual system broadly, supporting lens, corneal, and retinal health. While Retinalamin focuses specifically on retinal tissue via injection, Normoftal provides oral-based comprehensive eye support, making it accessible for daily maintenance of visual health. It modulates gene expression in ocular tissues to support lens transparency, corneal integrity, intraocular pressure regulation, and visual acuity preservation. Normoftal is particularly valuable for age-related vision decline, early cataracts, computer vision syndrome, and as oral maintenance following Retinalamin injection courses.
Indications
- Age-related vision decline and presbyopia
- Early cataract formation and lens opacity
- Computer vision syndrome and digital eye strain
- Intraocular pressure management (adjunctive)
- Corneal health and dry eye support
- Post-Retinalamin maintenance therapy
- General visual system preservation
- Myopia progression management (emerging)
Mechanism of Action
Age-related vision changes, lens opacity, digital eye strain, or corneal and retinal deterioration
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| Normoftal | 20 mg | Once daily | General eye health and visual maintenance |
| Normoftal | 20 mg | Twice daily for first month, then once daily | For active visual decline or post-Retinalamin maintenance |
Evidence Grade
GRADE C
Safety & Contraindications
- Synthetic bioregulator with favorable safety profile
- No significant adverse effects reported in clinical use
- Not a replacement for prescribed ophthalmological treatments
- Regular ophthalmological exams recommended during use
- Consult ophthalmologist for glaucoma or significant eye conditions
- Safe for long-term visual health maintenance
- Monitor intraocular pressure if history of glaucoma